secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001104659-26-004273
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi Therapeutics posts updated corporate presentation on website
-------------------------------------------------------------------

- Presentation available on company website as of January 16, 2026.
- No financial or operational updates disclosed in the filing text.
- Exhibit 99.1 appears incomplete; content not fully available for review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926004273/0001104659-26-004273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926004273/tm263373d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-004273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer